Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aldeyra Therapeu (NQ: ALDX )

8.340 USD -0.370 (-4.25%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Aldeyra Therapeu

< Previous 1 2 3 Next >
Notable Tuesday Option Activity: BLMN, CVX, ALDX
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Bloomin' Brands Inc (BLMN), where a total volume of 6,224 contracts has been traded... 
Tags Stocks
From Market News Video
January 2022 Options Now Available For Aldeyra Therapeutics (ALDX)
Investors in Aldeyra Therapeutics Inc (ALDX) saw new options begin trading today, for the January 2022 expiration. One of the key data points that goes into the price an option buyer is willing to pay,... 
Tags Stocks
From Market News Video
Aldeyra Therapeutics to Participate in the Virtual Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer of Aldeyra, will participate in a fireside conversation with... 
From Business Wire News Releases
Aldeyra Therapeutics to Participate in Upcoming Virtual Investor Conferences
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company developing novel immune-modulating therapies to treat ocular and systemic diseases, today announced that Todd C. Brady,... 
From Business Wire News Releases
How The Parts Add Up: VTWG Headed For $268
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Noteworthy Tuesday Option Activity: ALDX, CPLG, CAL
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Aldeyra Therapeutics Inc (ALDX), where a total volume of 5,320 contracts has been... 
Tags Stocks
From Market News Video
Notable Thursday Option Activity: CC, ALDX, FB
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Chemours Co (CC), where a total volume of 12,374 contracts has been traded thus far... 
Tags Stocks
From Market News Video
Aldeyra Therapeutics (ALDX) Q2 2021 Earnings Call Transcript
ALDX earnings call for the period ending June 30, 2021. 
Tags ALDX Market News
From Motley Fool
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags INM AUTL ARNA
From Benzinga
Aldeyra Therapeutics Reports Second-Quarter 2021 Financial Results and Recent Corporate Highlights
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company developing novel immune-modulating therapies to treat ocular and systemic diseases, today reported financial results for the... 
From Business Wire News Releases
Aldeyra Secures US Orphan Drug Tag For Its Retinitis Pigmentosa Candidate
TheFDA has granted orphan drug designationtoAldeyra Therapeutics Inc's(NASDAQ: ALDX) ADX-2191 to treat ... 
Tags Retinitis Pigmentosa Small Cap Benzinga
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers BeyondSpring (NASDAQ:BYSI) stock increased by 337.79% to $42.16 during Wednesday's pre-market session. The ... 
Tags CHNG BYSI OSUR
From Benzinga
Aldeyra Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ADX-2191 to Treat Retinitis Pigmentosa
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for ADX-2191 (methotrexate for intravitreal... 
From Business Wire News Releases
Aldeyra Therapeutics to Participate in Upcoming Virtual Investor Conferences
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that President and Chief Executive Officer Todd C. Brady, M.D., Ph.D. will participate in analyst-led fireside conversations at the... 
From Business Wire News Releases
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week endingJuly 30 amid earnings releases from big pharma companies. Most ... 
Tags YMAB Biotech KALA
From Benzinga
Aldeyra Therapeutics Schedules Webcast and Conference Call to Report Second-Quarter 2021 Financial Results and Discuss Recent Business Highlights
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call at 8:00 a.m. ET Thursday, August 5, 2021 to report financial results for the quarter ended June 30, 2021 and discuss... 
From Business Wire News Releases
XBI's Holdings Could Mean 74% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Aldeyra Stock Trading Higher On FDA Orphan Drug Tag For Primary Vitreoretinal Lymphoma Candidate
TheFDA has granted Orphan Drug DesignationtoAldeyra Therapeutics Inc's(NASDAQ: ALDX) ADX-2191 ... 
Tags News Market News ALDX
From Benzinga
Aldeyra Therapeutics Receives Orphan Drug Designation from the U.S. Food and Drug Administration for ADX-2191 to Treat Primary Vitreoretinal Lymphoma
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company for ADX-2191 (methotrexate for... 
From Business Wire News Releases
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock moved upwards by 67.6% to $14.28 during Monday's pre-market session. ... 
Tags BLCM Pre/Market Outlook Top Gainers
From Benzinga
Interesting ALDX Put And Call Options For March 2022
Investors in Aldeyra Therapeutics Inc (ALDX) saw new options become available this week, for the March 2022 expiration. One of the key data points that goes into the price an option buyer is willing to... 
Tags Stocks
From Market News Video
First Week of August 20th Options Trading For Aldeyra Therapeutics (ALDX)
Investors in Aldeyra Therapeutics Inc (ALDX) saw new options become available this week, for the August 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ALDX... 
Tags Stocks
From Market News Video
Aldeyra Therapeutics Joins the Russell 2000® and Russell 3000® Indexes
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company developing novel immune-modulating therapies to treat ocular and systemic diseases, today announced that the company was... 
From Business Wire News Releases
Aldeyra Therapeutics Clears Key Benchmark, Hitting 90-Plus RS Rating
Aldeyra Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. 
From Investor's Business Daily
Analysts Expect XBI Will Reach $216
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
From ETF Channel
Aldeyra Therapeutics to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer of Aldeyra, will participate in a fireside chat at the... 
From Business Wire News Releases
The Past Week's Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics, And More
Insider buying can be an encouraging signal for investors, especially when markets are near all-time highs. Some insiders have taken advantage of initial public offerings. A few chief executive... 
From TalkMarkets
The Past Week's Notable Insider Buys: Amphenol, Aldeyra, Werewolf Therapeutics And More
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Once again, ... 
From Benzinga
Aldeyra Therapeutics (ALDX) Q1 2021 Earnings Call Transcript
ALDX earnings call for the period ending March 31, 2021. 
From Motley Fool
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
From Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.